NASDAQ:ELEV

Elevation Oncology - ELEV News Today

$1.02

-0.02 (-1.92%)

(As of 01/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.01
▼
$1.04
50-Day Range: $0.75
▼
$1.16
52-Week Range: $0.72
▼
$5.20

Volume: 11,675 shs
Average Volume: 171,481 shs
Market Capitalization: $23.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.83

Institutional Ownership

Get Elevation Oncology News Delivered to You Automatically

ELEV Media Mentions By Week

ELEV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ELEV
News Sentiment
▼
1.02

0.72
▲
Average
Medical
News Sentiment

ELEV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ELEV Articles
This Week
▼
14

1
▲
ELEV Articles
Average Week

Source

Source	Headline
	How Will Early 2023 Layoffs Affect These 5 Biotech Stocks? (ELEV) marketbeat.com - January 25 at 4:03 AM
	Wedbush Analysts Raise Earnings Estimates for Elevation Oncology, Inc. (NASDAQ:ELEV) americanbankingnews.com - January 27 at 3:16 AM
	ELEV Elevation Oncology, Inc. seekingalpha.com - January 26 at 8:26 AM
	Brokers Offer Predictions for Elevation Oncology, Inc.'s FY2027 Earnings (NASDAQ:ELEV) americanbankingnews.com - January 26 at 3:44 AM
	Elevation Oncology, Inc. (NASDAQ:ELEV) Short Interest Update americanbankingnews.com - January 24 at 6:32 AM
	Elevation Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 9 at 8:02 AM
	Elevation Oncology CEO resigns as part of company prioritization effort msn.com - January 7 at 7:49 AM
	Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition finance.yahoo.com - January 6 at 12:40 PM
	Elevation Oncology to Participate at the JMP Securities Hematology and Oncology Summit finance.yahoo.com - November 30 at 8:25 AM
	Elevation Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress finance.yahoo.com - November 3 at 8:37 AM
	Merrimack Reports Second Quarter 2022 Financial Results finance.yahoo.com - August 4 at 5:42 PM
	Elevation Oncology to Participate at the Wedbush PacGrow Healthcare Conference finance.yahoo.com - August 3 at 10:04 AM
	Elevation Oncology Inc Stock News morningstar.com - July 30 at 5:46 AM
	Elevation Oncology Inc (ELEV) uk.investing.com - July 12 at 9:44 PM
	Short Volatility Alert: Elevation Oncology, Inc. uk.investing.com - July 12 at 9:44 PM
	Why Elevation Oncology Stock Is Rising uk.investing.com - May 27 at 11:36 AM
	Elevation Oncology Inc. barrons.com - May 27 at 6:35 AM
	Elevation Oncology Gets Fast Track Designation for Seribantumab to Treat Tumors Harboring NRG1 Gene Fusions morningstar.com - May 27 at 6:35 AM
	Elevation Oncology to Present Initial Seribantumab Proof-of-Concept Data from Phase 2 CRESTONE Study in Patients with Tumors Harboring NRG1 Fusions at ASCO 2022 finance.yahoo.com - May 26 at 8:34 PM
	Estimating The Intrinsic Value Of Elevation Oncology, Inc. (NASDAQ:ELEV) finance.yahoo.com - May 26 at 10:33 AM
	Elevation Oncology Shares Gain On FDA Fast Track Designation For Seribantumab In Tumor-Agnostic Settings msn.com - May 25 at 7:26 PM
	Elevation gets FDA fast track status for seribantumab to treat gene-specific solid tumors seekingalpha.com - May 25 at 9:42 AM
	Elevation Oncology Announces FDA Fast Track Designation Granted to Seribantumab for the Tumor-Agnostic Treatment of Solid Tumors Harboring NRG1 Gene Fusions finance.yahoo.com - May 25 at 9:42 AM
	Merrimack Reports First Quarter 2022 Financial Results apnews.com - May 5 at 6:38 PM
	Elevation Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress finance.yahoo.com - May 5 at 8:37 AM
	Elevation Oncology Inc - Stock Quote ELEV morningstar.com - April 29 at 10:26 PM
	ReviR Therapeutics Announces Dr. David Dornan as Independent Board Director markets.businessinsider.com - April 28 at 10:45 AM
	Elevation Oncology Announces Initial Data from Phase 2 CRESTONE Study of Seribantumab Selected for Oral Presentation at ASCO 2022 finance.yahoo.com - April 27 at 12:38 PM
	Is Elevation Oncology (NASDAQ:ELEV) In A Good Position To Deliver On Growth Plans? finance.yahoo.com - March 24 at 2:53 PM
	Elevation Oncology Appoints David Dornan, Ph.D., as Chief Scientific Officer finance.yahoo.com - March 22 at 6:04 AM
	Wedbush Maintains Outperform on Elevation Oncology, Lowers Price Target to $21 benzinga.com - March 4 at 2:26 PM
	Elevation Oncology GAAP EPS of -$0.41 beats by $0.18 seekingalpha.com - March 3 at 4:51 PM
	Elevation Oncology Reports Fourth Quarter and Full Year 2021 Financial Results finance.yahoo.com - March 3 at 8:15 AM
	Elevation Oncology to Participate at Upcoming Virtual Investor Conferences finance.yahoo.com - March 1 at 4:35 PM
	Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update apnews.com - February 28 at 8:56 PM
	Vertex Ventures HC Announces the Addition of Christine Brennan, Ph.D. as Managing Director finance.yahoo.com - February 18 at 1:37 AM
	Elevation Oncology, Inc. Common stock (ELEV) nasdaq.com - January 30 at 8:50 PM
	Elevation Oncology Highlights 2021 Achievements and Outlines Expected 2022 Milestones finance.yahoo.com - January 10 at 7:33 AM
	Elevation Oncology to Present at the H.C. Wainwright BIOCONNECT Virtual Conference finance.yahoo.com - January 6 at 8:06 AM
	Elevation Oncology to Present at the 40th Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 5 at 10:20 AM
	Elevation Oncology Inc reuters.com - December 4 at 7:14 PM
	Elevation Oncology to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference finance.yahoo.com - November 18 at 12:57 PM
	Elevation Oncology Reports Third Quarter 2021 Financial Results finance.yahoo.com - November 12 at 8:33 AM
	Elevation Oncology's Seribantumab Included as Part of a Case Series Presentation at the Australasian Gastro-Intestinal Trials Group 2021 Annual Scientific Meeting finance.yahoo.com - October 14 at 7:20 AM
	Elevation Oncology Inc. Rings the Nasdaq Stock Market Closing Bell nasdaq.com - September 29 at 4:29 PM
	We're Hopeful That Elevation Oncology (NASDAQ:ELEV) Will Use Its Cash Wisely nasdaq.com - September 25 at 1:10 PM
	Elevation Oncology (NASDAQ:ELEV) Is In A Good Position To Deliver On Growth Plans finance.yahoo.com - September 25 at 1:10 PM
	Elevation Oncology to Present at the H.C. Wainwright 23rd Annual Global Investment Conference finance.yahoo.com - September 7 at 2:01 PM
	Elevation Oncology Reports Second Quarter 2021 Financial Results finance.yahoo.com - August 12 at 8:22 PM
	Elevation Oncology to Present at the 12th Annual Wedbush PacGrow Healthcare Conference finance.yahoo.com - August 4 at 7:38 AM
	Elevation Oncology Announces Pricing of Initial Public Offering finance.yahoo.com - July 22 at 8:26 PM

Get Elevation Oncology News Delivered to You Automatically

This page (NASDAQ:ELEV) was last updated on 1/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Elevation Oncology - ELEV News Today

ELEV Media Mentions By Week

ELEV Media Sentiment

ELEV News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info